Comerica Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $472K | Buy |
27,575
+257
| +0.9% | +$4.4K | ﹤0.01% | 1899 |
|
2025
Q1 | $1.74M | Sell |
27,318
-1,146
| -4% | -$73.1K | 0.01% | 1190 |
|
2024
Q4 | $3.46M | Sell |
28,464
-1,712
| -6% | -$208K | 0.01% | 865 |
|
2024
Q3 | $3.77M | Sell |
30,176
-4,031
| -12% | -$503K | 0.01% | 838 |
|
2024
Q2 | $5.4M | Buy |
34,207
+30,871
| +925% | +$4.88M | 0.02% | 636 |
|
2024
Q1 | $432K | Buy |
3,336
+2,770
| +489% | +$359K | ﹤0.01% | 1943 |
|
2023
Q4 | $54.6K | Sell |
566
-102,701
| -99% | -$9.9M | ﹤0.01% | 2692 |
|
2023
Q3 | $12.5M | Buy |
+103,267
| New | +$12.5M | 0.07% | 293 |
|
2022
Q4 | $10.7M | Buy |
82,228
+37,502
| +84% | +$4.88M | 0.08% | 256 |
|
2022
Q3 | $4.95M | Buy |
+44,726
| New | +$4.95M | 0.04% | 511 |
|
2021
Q1 | – | Sell |
-29,270
| Closed | -$2.88M | – | 2361 |
|
2020
Q4 | $2.88M | Buy |
29,270
+9,422
| +47% | +$925K | 0.02% | 1065 |
|
2020
Q3 | $2.73M | Sell |
19,848
-265
| -1% | -$36.5K | 0.02% | 909 |
|
2020
Q2 | $3.31M | Sell |
20,113
-3,618
| -15% | -$595K | 0.03% | 741 |
|
2020
Q1 | $2.88M | Sell |
23,731
-890
| -4% | -$108K | 0.03% | 698 |
|
2019
Q4 | $2.9M | Sell |
24,621
-1,350
| -5% | -$159K | 0.02% | 870 |
|
2019
Q3 | $2.17M | Buy |
25,971
+2,044
| +9% | +$171K | 0.02% | 1043 |
|
2019
Q2 | $3.69M | Sell |
23,927
-431
| -2% | -$66.4K | 0.03% | 686 |
|
2019
Q1 | $3.08M | Sell |
24,358
-575
| -2% | -$72.8K | 0.03% | 817 |
|
2018
Q4 | $2.89M | Buy |
24,933
+5,173
| +26% | +$599K | 0.02% | 835 |
|
2018
Q3 | $2.65M | Buy |
19,760
+3,386
| +21% | +$455K | 0.02% | 932 |
|
2018
Q2 | $2.25M | Buy |
16,374
+172
| +1% | +$23.6K | 0.02% | 1190 |
|
2018
Q1 | $1.27M | Sell |
16,202
-673
| -4% | -$52.9K | 0.01% | 1506 |
|
2017
Q4 | $1.11M | Buy |
+16,875
| New | +$1.11M | 0.01% | 1585 |
|